lilly glp 1 injection Lilly's Easy-to Use Once-Weekly GLP-1 Agonist Trulicity Approved in Europe Novo, Lilly buoyed by fast-growing

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who take GLP-1 medications are about 30% less likely to develop breast cancer than those who do not take GLP-1 medications.

Stopping GLP-1 receptor agonists 14 days prior to total hip or knee arthroplasty may reduce several key risk factors associated with anesthesia complications, according to results presented here.“Specifically for semaglutide, stopping that medication 14 days before surgery is safest based upon the dataset that we have to minimize your risks with anesthesia, especially when

Stopping semaglutide after weight loss requires careful planning

This event will bring together WHO leadership, Ministers of Health, global experts and civil society to raise awareness and promote the adoption of this new standard in chronic obesity care

The PatchAid Berberine Patch delivers a plant-based formula straight through your skin

Additionally, encouraging results from SURMOUNT trials and ongoing SURPASS-CVOT studies will shed more light on cardiovascular safety in the future